SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001193125-11-306300
Filing Date
2011-11-10
Accepted
2011-11-10 12:55:58
Documents
6
Period of Report
2011-11-07
Items
Item 1.01: Entry into a Material Definitive Agreement
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 FORM 8-K d254287d8k.htm 8-K 23450
2 UNDERWRITING AGREEMENT d254287dex11.htm EX-1.1 129475
3 OFFICERS' CERTIFICATE d254287dex42.htm EX-4.2 202056
4 OPINION OF LATHAM & WATKINS LLP d254287dex51.htm EX-5.1 18392
5 GRAPHIC g254287g40x42.jpg GRAPHIC 5403
6 GRAPHIC g254287g45i49.jpg GRAPHIC 3620
  Complete submission text file 0001193125-11-306300.txt   387363
Mailing Address ONE AMGEN CENTER DRIVE MAIL STOP 24-1-B THOUSAND OAKS CA 91320-1799
Business Address ONE AMGEN CENTER DRIVE MAIL STOP 24-1-B THOUSAND OAKS CA 91320-1799 (805)313-1762
AMGEN INC (Filer) CIK: 0000318154 (see all company filings)

IRS No.: 953540776 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 000-12477 | Film No.: 111194288
SIC: 2836 Biological Products, (No Diagnostic Substances)